VGXI Blog & News

Welcome to the VGXI blog where we examine scientific trends, innovation, technological advancements in plasmid DNA manufacturing, and uncover how next-generation therapeutics are shaping the future of medicine and improving patients’ lives.

Stephanie Burke Named as VGXI’s New Chief Accounting Officer

Leading plasmid DNA CDMO VGXI, Inc. announces the appointment of Stephanie Burke as its new Chief Accounting Officer. VGXI, Inc.,[...]

  Read More

VGXI’s Full Spectrum Plasmid DNA Solutions: From Discovery to Commercialization

Plasmids are small, circular, double-stranded DNA molecules that have become indispensable tools in the life sciences. They are primarily found[...]

  Read More

VGXI, Inc. Names Jeff Whitmore as New Chief Commercial Officer

Leading plasmid DNA CDMO VGXI, Inc. announces the appointment of Jeff Whitmore as its new Chief Commercial Officer. VGXI Inc.,[...]

  Read More

VGXI Celebrates the Grand Opening for its New Headquarters and Manufacturing Facility

With original operations based in The Woodlands, TX, industry recognized plasmid DNA contract manufacturer VGXI, Inc. celebrated the official Grand[...]

  Read More

An Introduction to DNA and Vaccines

Vaccines are one of humanity’s most important inventions as they help protect public health and save millions of lives every[...]

  Read More

VGXI Announces Grand Opening Celebration for New Headquarters and Manufacturing Facility

Specialized plasmid DNA contract manufacturer VGXI, Inc. announces date for the Grand Opening celebration of its new headquarters and expanded[...]

  Read More

VGXI Celebrates First Look Event at New Manufacturing Facility

VGXI opened the doors of its new headquarters and manufacturing facility on 09Apr22 to provide friends and employee families a[...]

  Read More

VGXI Official COVID-19 Statement

To our Valued Clients and Business Partners, VGXI’s top priority is to continue delivering the highest quality DNA products and[...]

  Read More

VGXI Partner IMM Announces $12M NIH Grant to Support Phase 1 Clinical Trial of a DNA Vaccine for the Prevention of Alzheimer’s Disease

Texas-based CDMO VGXI, Inc. is excited to announce that its partner, The Institute for Molecular Medicine, has recently been awarded[...]

  Read More